Accelerate to discover

Back to filter

Related topics

Fluxion Biosciences and National Cancer Institute cooperate to validate IsoFlux for sequencing

Fluxion Biosciences

Jun 12, 2019

Fluxion with IsoFlux has partnered with the Cleveland Clinic. They are aiming to improve sensitivity by timing the...

New insight into Cas9 off-target activity

LUMICKS

Jun 7, 2019

Scientists at the MRC London Institute of Medical Sciences and AstraZeneca studied how CRISPR-Cas9 differentiates...

IncuCyte virtual event: Dimension of time - from culture to assay

Sartorius

Jun 5, 2019

This event offers an overview of how live-cell analysis enables real-time analysis for the full workflow of the cells....

A novel method for isolating high-quality UHMW DNA from animal and human tissues

BioNano Genomics

May 31, 2019

New isolation protocol for isolating high-quality UHMW DNA from 10 mg of freshly frozen or liquid-preserved animal and...

Jun 18, 2019

From incubation to publication with IncuCyte S3 live-cell imaging system

Sartorius

May 29, 2019

Over 2000 peer-reviewed publications worldwide and growing. Explore the IncuCyte publications library, an up-to-date...

ParaVision 7 software

Bruker Biospin

May 27, 2019

The preclinical MRI software ParaVision 7 delivers unsurpassed image quality and enhanced productivity for both routine...

HLS-CATCH: Cas-9 assisted gene purification

Sage Science

May 24, 2019

The CATCH process  provides researchers with the most direct access to genes for study. Target regions are defined with...

Jun 18, 2019

Introducing the first EV isolation column capable of running 100 mL samples.

IZON

May 21, 2019

As the EV field continues to grow and advance, so has the need for scalability in EV isolation. Izon is addressing this...

Show all topics (10)

Fluxion launches BioFlux Extended Flow Module

Apr 11, 2016

Fluxion Biosciences announced that it has launched its BioFlux Extended Flow module for live cell analysis. The module consists of a new 6-well plate consumable and interface; it is now available and shipping to customers.

BioFlux provides the ability to emulate physiological flow and shear forces in an in vitro model, while maintaining a convenient well plate format. The system enables a multitude of assays that require precise control of the cellular micro-environment, including control of shear forces, liquid composition, gas, and temperature. BioFlux is widely used in basic research and drug development around the world by hundreds of recognized industry leaders (Pfizer, Amgen, BMS, Merck, Bayer), government labs (NIH, Walter Reed Research Center, VA Medical Center) and leading research institutions (Harvard, UC San Francisco, U. Michigan, U. Pennsylvania, Yale, and Oxford).

According to Dr. Bryan Haines, Global Product Director, “BioFlux extended flow plates were developed to address a frequent request of our customers: the need to remove flow time limitations from their assays. The new consumable and 6-well interface accomplish that, while continuing to integrate seamlessly into existing experimental protocols. Using the BioFlux Quattro Array, 12 experiments can be performed over extended time periods of up to 21 days.”

The Extended Flow Module, including consumables and a 6-well interface, is targeted at applications where longer cell or microbial growth under flow conditions is required. The new consumable extends the flow time significantly, from 31 hours using BioFlux 24-well plates at a shear of 1 dyn/cm2, to 110 hours at the same shear using the new extended flow plates. At low flow rates (0.15 dyn/cm2), BioFlux channels can now be kept under perfusion for up to 21 days. Long perfusion times are important for applications such as tuberculosis and urinary tract infection research.

“The introduction of the BioFlux Extended Flow Module provides great validation of our new rapid design-to-product development process. In addition to this new plate type, this process is being used to provide a cost-effective path for the production of customer-specific designs and will enable a much faster response time to develop new capabilities for the BioFlux system,” said Cristian Ionescu-Zanetti, CTO of Fluxion. “With its unique capability to mimic conditions in the body, now for much longer periods of time, the Extended Flow Module is a significant advance that provides for a new class of experiments using the BioFlux system.”

Technical breakthrough
Product news

Related technologies: Cell interaction studies

Brand profile

Fluxion Biosciences

With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.

Related products

Core control system, integrated to any inverted microscope to introduce flow to your research

show detail

System that offers a fully-integrated solution for automated, high throughput shear flow assays

show detail

Measures microfluidic flow cell arrays in the dynamic environment instead of the stagnant

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey